T1	Participants 66 81	type 2 diabetes
T2	Participants 572 596	type 2 diabetes subjects
T3	Participants 879 923	8 patients, 5 of whom were insulin-requiring
T4	Participants 1516 1537	type 2 diabetes group
T5	Participants 741 756	type 2 diabetes
